CARLSBAD, Calif.--(BUSINESS WIRE)--April 10, 2006--Invitrogen Corporation (Nasdaq:IVGN - News) today announced it has named former NIH stem cell section chief Mahendra Rao, MD, Ph.D. Vice President, Research, Stem Cells and Regenerative Medicine. In this role, Dr. Rao will lead the research efforts for Invitrogen's recently formed Stem Cell and Regenerative Medicine business. Invitrogen's efforts in regenerative medicine provide support technologies for applications across the range of nearly all forms of stem cell research.
